HUS2200041I1
(en )
2022-09-28
Anti-cd3 antibodies and methods of use
CL2016002462A1
(en )
2017-06-23
Anti-ox40 antibodies and methods of use
DK3353212T3
(en )
2021-12-20
Optimized bispecific anti-CD3 antibodies and uses thereof
KR102355950B9
(en )
2023-10-26
Antibodies to TIGIT
IL246693B2
(en )
2023-03-01
Antibody molecules to tim-3 and uses thereof
CL2016001102A1
(en )
2017-02-10
Novel anti-claudin antibodies and methods of use.
CL2015002562A1
(en )
2016-03-04
Anti-b7-h4 antibodies and immunoconjugates
DK3149042T3
(en )
2019-11-04
PD-L1 antibodies and uses thereof
DK3026062T3
(en )
2020-10-12
ANTI-PD-1 ANTIBODY AND ITS USE
DK2970460T3
(en )
2020-06-02
Anti-IL-33 Antibodies and Uses thereof
DK3079719T3
(en )
2019-11-18
ANTI-SIGLEC-8 antibodies and methods for their use
DK3086807T3
(en )
2022-09-19
Antibodies and methods of use
TH1601003592A
(en )
2018-09-06
Anti-CD3 antibody and how to use it
TH1601003401A
(en )
2018-10-25
Anti-DPEP3 antibody What's new and how to use it?
TH1601000935A
(en )
2018-06-07
Anti-PRLR antibodies and their uses
TH1601000450A
(en )
2018-05-24
Anti-activin A antibodies and their use
TH1501005356A
(en )
2018-10-25
Anti-IL-33 Antibody and Its Uses
TH1501003909A
(en )
2017-11-16
Antibodies to PDGFR-beta and their uses
TH1501007746A
(en )
2018-10-04
Anti-PD-1 Antibody and Its Uses
TH1501006781A
(en )
2018-05-17
Anti-Voltichoic Antibodies and Conjugates
TH1501006571A
(en )
2018-10-25
Modified antibodies binding to human FCRN and methods of use
TH1501005612A
(en )
2018-03-16
Humanized anti-CD134 (OX40) antibody and its uses
TH1501004169A
(en )
2018-06-21
Antibody production for CDH19 and CD3